My first impression is that I think it may be quite hard to construct a testable theory from this, given the vast complexity of the brain and that "something faulty in neurological signaling related to synapses" still seems quite vague for the beginning.
Yes, the theory isn't very specific, but I don't think anyone can be at this stage.
It does predict that studying the neural pathways that cause sickness behavior and synapse communication involved in this will be more fruitful for ME/CFS than all the things the field is pursuing now.
I think the main points I outlined are pretty straightforward, logical, and based on the (few) reliable data that we have. Yet the entire field seems to be pursuing almost everything else but this, and in (what seems to be at least) a chaotic, non-systematic way. Blood clots, endothelial dysfunction, reduced blood flow and hypoxia, viral persistence, antibodies, mitochondrial dysfunction, red blood cell deformity, the mTOR pathway, reduced microbiome diversity, CCI, mRNI, extracellular vesicle cargo, invasive cardiopulmonary exercise testing, etc. Most of these do not fit well with the framework and datapoints that we already have about ME/CFS. Not saying they should not be studied or that it is foolish to do so, but they do not seem the most obvious places to look.
Part of it is probably that brain neurology is hard to study.
Suppose ME/CFS is similar to a ongoing sickness response in acute infection, does one then see if one can characterise a sickness response in mice and see which drugs can elevate this response?
Yes, this sounds interesting. I haven't read much about what is known about this. Hope this is something that we can pursue more on the forum.